Sec Form 3 Filing - Peloton Equity AeroCare SPV I, L.P. @ AdaptHealth Corp. - 2021-02-02

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Peloton Equity AeroCare SPV I, L.P. 2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 10 GLENVILLE STREET 3. Date of Earliest Transaction (MM/DD/YY) 02/02/2021 (Street) GREENWICH, CT06831 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 3,466,826 ( 1 ) D ( 2 ) Class A Common Stock 328,260 ( 1 ) I See Footnote ( 3 ) Class A Common Stock 1,108,519 ( 1 ) I See Footnote ( 4 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series C Preferred Stock ( 5 ) ( 5 ) ( 5 ) Class A Common Stock 3,214,007 ( 1 ) D ( 2 ) Series C Preferred Stock ( 5 ) ( 5 ) ( 5 ) Class A Common Stock 306,087 ( 1 ) I See Footnote ( 3 ) Series C Preferred Stock ( 5 ) ( 5 ) ( 5 ) Class A Common Stock 1,033,644 ( 1 ) I See Footnote ( 4 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Peloton Equity AeroCare SPV I, L.P. 10 GLENVILLE STREET GREENWICH, CT06831 X Peloton Equity AeroCare SPV II, L.P. 10 GLENVILLE STREET GREENWICH, CT06831 X Peloton Equity I, L.P. 10 GLENVILLE STREET GREENWICH, CT06831 X Peloton Equity GP, LLC 10 GLENVILLE STREET GREENWICH, CT06831 X FERRER CARLOS A 10 GLENVILLE STREET GREENWICH, CT06831 X Signatures Peloton Equity AeroCare SPV I, L.P., By: Peloton Equity GP, LLC, its general partner By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member 02/04/2021 Signature of Reporting Person Date Peloton Equity AeroCare SPV II, L.P., By: Peloton Equity GP, LLC, its general partner By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member 02/04/2021 Signature of Reporting Person Date Peloton Equity I, L.P., By: Peloton Equity GP, LLC, its general partner By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member 02/04/2021 Signature of Reporting Person Date Peloton Equity GP, LLC, By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member 02/04/2021 Signature of Reporting Person Date Carlos Ferrer, by: /s/ Carlos Ferrer 02/04/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On December 1, 2020, the Issuer entered into Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc. ("Merger Sub I"), AH Apollo Merger Sub II Inc. ("Merger Sub II"), Peloton Equity, LLC (the "Stockholder Representative") and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and Series C Preferred Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Class A Common Stock and Series C Preferred Stock, respectively, pursuant to the Merger Agreement. ( 2 )Shares held by Peloton Equity AeroCare SPV I, L.P. ("Peloton AeroCare I"). Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. ( 3 )Shares held by Peloton Equity AeroCare SPV II, L.P. ("Peloton AeroCare II"). Peloton Equity GP is the general partner of Peloton AeroCare II. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. ( 4 )Shares held by Peloton Equity I, L.P. ("Peloton Equity I"). Peloton Equity GP is the general partner of Peloton Equity I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. ( 5 )Upon approval by the stockholders of the Issuer pursuant to the terms of the Merger Agreement, each share of Series C Preferred Stock will be convertible on a 100-for-one basis into the number of shares of the Issuer's Class A Common Stock shown in Column 3, subject to adjustments as set forth in the Certificate of Designation, Preferences and Rights of Series C Convertible Preferred Stock, Par Value $0.0001, of AdaptHealth Corp. dated as of January 29, 2021. The Series C Preferred Stock has no expiration date.

Remarks: Theodore B. Lundberg, a managing member of Peloton Equity GP, was appointed to the board of directors of the Issuer on February 2, 2021 and has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Lundberg's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Lundberg has filed a separate Section 16 report disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid O MB Number.